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ABSTRACT 
 
Objective: 
Currently, there does not exist a cohesive and predictive set of criteria that can be used to 
identify patients that are at risk of being non-adherent to antibiotic regimens. In this study, we 
sought to answer the question of whether patients’ knowledge of the scientific background of 
antibiotic resistance is related to their likelihood to adhere to antibiotic regimens. Additionally, 
we explored other facets of the profiles of adherent and non-adherent subjects. 
 
Methods: 
All responses were collected via questionnaire. Subjects were split into two groups (adherent and 
non-adherent) based upon four patient-behavior questions. These two groups of subjects were 
compared in a variety of ways to test for significant differences in categories such as science 
knowledge, age, and self-reported understanding of the problem of antibiotic resistance. 
 
Results: 
It was determined that the adherent group of subjects had significantly higher science scores 
(mean=5.46, n=384) than the non-adherent subjects (mean=4.99, n=460); t(842)= -2.73, 
p=0.0064.  Subjects majoring in STEM were more likely to be adherent than biology or non-
STEM majors. There were no differences in adherence or science scores across age groups. 
About 26% of subjects had not previously heard of the problem of antibiotic resistance. 
 
Discussion: 
Increasing patient education on the topic of antibiotic resistance could increase patient 
adherence, which could in turn lead to a reduction in the rate at which bacteria develop 
resistance. Initiatives to educate patients and health care professionals have the potential to 
increase understanding and improve rates of adherence. 
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CHAPTER 1: INTRODUCTION 
Objective 
 Currently, there does not exist a cohesive and predictive set of criteria that can be used to 
identify patients that are at risk of being non-adherent to antibiotic regimens. Non-adherence to 
prescribed regimens of antibiotic treatment is a problem that has been demonstrated to have 
potentially life threatening downstream effects on individual patients and the health of the 
community at large. In this study, we sought to answer the question of how patients’ knowledge 
of the scientific background of antibiotic resistance is related to their likelihood to adhere to 
antibiotic regimens. In addition to collecting information on the respondents’ (i) likelihood to 
adhere and (ii) scientific knowledge, we collected responses to a variety of questions related to 
antibiotics and demographics in order to enhance the understanding of differences between the 
profiles of adherent and non-adherent patients. 
The golden era of medicine 
 The term “antimicrobial” refers to any compound whose action kills or stops the growth 
of microorganisms. For the purposes of this study, the term “antibiotics” will be used to refer to 
drug treatments that are prescribed by doctors with the intent of killing or inhibiting bacteria (and 
not viruses or other parasites) that are causing a disease state in patients.1  
Antibiotics have not always been available to medical practitioners. Prior to the early 
1900s, infections were treated according to anecdotal accounts, and medicinal folklore. In some 
cases, these folk recipes contained components which are known today to have legitimate 
antimicrobial properties, such as active ingredients from various species of molds. The vast 
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majority of such ancient recipes, however, have been found to exhibit minimal antimicrobial 
activity.2 In the 1920s and 1930s, bacteriophage therapy was used as a treatment for bacterial 
infections, but the mechanisms by which it was successful were poorly understood.3 Excitement 
at phage therapy’s potential led to careless applications, which led to uncertain results and a 
general decline of favorability as other treatments (e.g. antibiotics) became available in the years 
to follow.3 
Louis Pasteur observed the ways that microorganisms kill each other in the late 19th 
century. He commented on the apparent potential to harness the microbes’ capacity to kill other 
microbes.4 In 1928, Alexander Fleming, a Scottish biologist and pharmacologist, noticed that 
fungi of the genus Penicillium were capable of killing a number of bacteria growing in petri 
dishes. Fleming carried out studies on other molds, and found one particular characteristic of 
Penicillium that made it stand out from the others; the broth in which the Penicillium grew 
contained antibiotic properties itself. His efforts to extract crude preparations from the molds and 
use them to treat infections proved unsuccessful without the aid of more experienced chemists.5 
Fleming named the active compound from the mold “penicillin” – a term that is familiar 
and standard in modern times. Although he didn’t know it at the time, penicillin exerts its 
bactericidal effects by inhibiting the production of peptidoglycan – a molecular component that 
is critical in the construction of bacterial cell walls.6 Penicillin is actually a broad group of 
antibacterial compounds that all exhibit this mode of action, and contain a common structural 
motif, the β-lactam ring.6 
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The first commercially available antibiotic was not penicillin, however. Prontosil, a 
sulfonamide prodrug drug developed in 1932 by a team led by Gerhard Domagk, was the first 
drug to open the field of medicine to the golden era of antibiotics.7 Prontosil was found to have 
effective potential versus Gram positive organisms, especially Streptococci.7 
It was not until the 1940s that penicillin was able to be mass produced and used to treat 
and prevent infections. In the years leading up to that time, research teams were having difficulty 
acquiring yields large enough to provide significant returns on the investment of their time and 
resources. The United States determined that having a large supply of antibiotics would be a 
critical tool to have at the Allies’ disposal during World War II. In 1943, the War Production 
Board detailed a plan that was centric about the ability of the Allied forces throughout Europe to 
be supplied by a source of penicillin.8 Luckily, as a result of research into corn steep liquor (a by-
product of corn wet-milling), methods for mass culture of Penicillium were discovered and 
implemented, allowing the U.S. to supply the Allies with an impressive 2.3 million doses of 
penicillin for the war.9 This availability of medicine reduced casualties from battlefield 
infections, providing the Allies with a tactical edge. Microorganisms’ influence on battlefield 
outcomes was thus curbed in the 20th century as a result of the utilization of antibiotics derived 
from naturally occurring sources. 
An urban legend states that in 1968, the US Surgeon General, Dr. William H. Stewart, 
declared that “It is time to close the book on infectious diseases, and declare the war against 
pestilence won.” Although it appears as though he never made such a statement, that belief was 
certainly held by some academics at the time.10 The practice of medicine since the 
implementation of antibiotics began to rest upon the assumption that infections would largely be 
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treatable with antibiotics, and researchers began to allocate their resources in other directions. 
Notably, a 1968 US government report said 
“The emphasis of epidemiologic investigation has shifted markedly in the last two 
decades. A decline in interest in the infectious diseases and increase in concern with the 
noninfectious diseases have resulted from the change in relative importance of these categories 
of disease in many parts of the world, including the United States. It is also recognized that, 
although major tasks still remain in the improvement of control over the infectious diseases, the 
contribution of epidemiology to the development of control methods is largely past —new 
advances are being made predominantly as the result of work in the experimental laboratory and 
through the better application of existing knowledge. On the other hand, the identification of 
cigarette smoking as the major cause of this century’s epidemic of lung cancer has clearly 
demonstrated the potential contribution of epidemiologic research at the present stage of 
knowledge of those chronic diseases that now constitute the predominant health problems in this 
country.”9 
At the time, it seemed as though modern scientific research had become dominant over 
the threat of infection and that it was time to move on to conquering other questions of the 
biomedical sciences. 
Modern trends of antibiotic use 
 In recent times, researchers have been able to develop new varieties of antibiotics that 
impact different subclasses of bacteria. In addition to seeking new naturally occurring 
antimicrobial compounds, today it is possible to synthesize new compounds from scratch and to 
modify existing compounds to serve our specific needs. Large scale drug screens that test the 
bactericidal potential of hundreds of thousands of compounds at a time can be used to rapidly 
identify potential candidates for future therapies. 
 Unfortunately, today we find ourselves in a time when many of the simplest, most readily 
developed antibiotics have been researched and produced. Drug screens often return hits of 
compounds that are already thoroughly investigated and employed, and new candidate 
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compounds are fewer and further in between. Only about 0.1% of drugs even make it to the stage 
where they are tested in human clinical trials.11 
 The resulting slow-down in production of novel antibiotics would not be a problem were 
it not for the development of antibiotic resistance. Bacteria are remarkably well adapted to 
evolve to be resistant to antibiotic compounds. Even mutations at a single base pair of the 
genome (single nucleotide polymorphisms, or SNPs), can cause the development of a resistant 
strain. Prokaryotic genomic innovation is facilitated by mechanisms such as horizontal gene 
transfer, which allows for bacteria to transfer plasmids containing genetic information to 
neighboring bacteria (sometimes of different genera), bucking the classically understood rule of 
the downward generational movement of genetic material.12 This horizontal gene transfer is 
especially important to the topic of antibiotic resistance because genes encoding anti-antibiotic 
elements can be quickly passed from one member of the bacterial community to another. 
Conjugative plasmids (a form of horizontal gene transfer) often contain such information, 
allowing organisms to quickly adapt en masse to life inside a new host environment.12 
 Thus, as soon as a single organism comes across (via a mutation event or otherwise) a 
gene conferring antibiotic resistance, there is a potential for that gene to quickly spread among 
neighboring organisms. It is not only the progeny of that originating mother cell, but also any 
neighboring cells that might be able to receive a protective plasmid from the mother. 
 This capacity to share plasmids among bacteria has led to the consideration of bacterial 
communities of genes. It is not reasonable to assume that a bacterium will only have access to 
the deoxyribonucleic acid (DNA) that it was given when it split off from its mother cell. 
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Microorganisms can even bypass the need to have a particular antibiotic resistance gene at all 
through the implementation of nanotubes; there is evidence to suggest that bacteria growing in 
biofilms are capable of using nanotubes to share small molecules, proteins, and nucleic acids in a 
direct fashion. These proteins can include enzymes that confer antibiotic resistance.13 
One example of an enzyme that can confer resistance to antibiotics can be found in 
bacteria that have a β-lactamase. The penicillin class of drugs contains a β –lactam ring and 
inhibits cell wall synthesis, causing bacterial cell death. These drugs are readily inactivated by β 
-lactamase enzymes, which cleave the β-lactam ring of the antibiotic compounds, rendering them 
ineffective.14 Over time, as patients are prescribed penicillin, the bacterial strains that are 
susceptible to the drugs are killed, leaving the bacteria that can produce β-lactamase to survive in 
the resulting ecological niche. When β-lactam drugs are prescribed today, they are often coupled 
with β-lactamase inhibitors, compounds that stop bacteria from cleaving the β-lactam ring in 
penicillin. This is regarded as the most successful strategy to gain control over β-lactam resistant 
bacteria.15 The fact that such drug cocktails are necessary is a testament to the rapidity with 
which bacterial agents have come to circumvent interventions. 
 In some countries around the world, such as Jordan, antibiotics are available over the 
counter without a prescription.16 This contrasts with systems where antibiotics are only available 
by prescription from a physician. The rationale behind the prescription-based system is to reduce 
the incidence rate of the use of antibiotics without sufficient cause. Antibiotics are often 
disruptive to commensal gut flora.17 These commensal organisms are beneficial to their host’s 
health and capacity to digest food. For example, the normal intestinal bacteria in humans produce 
vitamin K2.18 Vitamin K is essential to several human processes, notably the production of 
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clotting factors.19 In the absence of clotting factors, there is an increased risk of abnormal blood 
loss resulting from injuries. 
The end of an era 
The consistent use of antibiotics over the last 70 years has applied a relentless selective 
pressure to the microbes capable of infecting humans. As a result, the artificial selection of 
antibiotic-resistant bacteria has been a constantly looming threat. This is a simple form of an 
evolutionary process where those bacteria that are capable of surviving the antibiotics are the 
only ones capable of reproducing, thus exponentially expanding the impact of their antibiotic-
resistant genes. When antibiotic resistance develops, it tends to first be observed in hospital 
environments, and then spread to the community.20 
The rate at which antibiotic resistant strains of bacteria emerge is hastened by increased 
bacterial exposure to antibiotics, such as with human therapeutic treatment. This effect is 
magnified when non-adherent patients stop taking their doses partway through a regimen; 
stopping early gives surviving bacteria a chance to replicate that they might not have otherwise 
had, promoting the possibility of the propagation of resistant genes.21 
The development of resistance to antibiotic compounds, however, is not a uniquely 
modern phenomenon. An analysis of DNA from 30,000 year old Beringian permafrost revealed 
genes encoding resistance to β-lactam, tetracycline, and glycopeptide antibiotics.22 It is apparent 
that the development of antibiotic resistance is an inevitability.21 
In 1942, penicillin resistance was demonstrated in a lab setting, where it was induced by 
slowly increasing the concentration of penicillin in which bacteria were grown.23 For example, 
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the initial medium in which the bacteria were grown had only a very low concentration of 
penicillin. When it was time to give the bacteria a fresh supply of growth medium, slightly more 
penicillin was added to the mix. This gradual process selected for the bacteria that were best able 
to survive. 
The mass production of penicillin began in 1943. Penicillin resistance was reported in a 
clinical Australian strain of Streptococcus pneumoniae in 1967.24 In 1974, a case of resistance 
was reported in the United States.24 By 1980, it was estimated that approximately 3-5% of all S. 
pneumoniae were resistant to penicillin, and by 1998, 34% of a sample of S. pneumoniae were 
found to be resistant.25 A 2014 study on the prevalence of antibiotic resistance genes among 
clinical Streptococcal isolates from pregnant women revealed that 97.6% of the isolates 
contained the tetM gene, which encodes a soluble protein that helps to shield the bacterial cell’s 
ribosomes from the otherwise inhibitory action of tetracycline antibiotics.26, 27 The product of 
tetM acts in conjunction with the product of several other genes (tetQ and OtrA) to protect the 
bacterial ribosomes form the effect of tetracycline. In 2013, the number of S. pneumoniae that 
were found to be resistant to at least one drug was around 30%.28 Some regions of the United 
States have seen proportions of penicillin resistant S. pneumoniae as high as 40-50%.29 
Mycobacterium tuberculosis (Mtb) is another example of a tremendously dangerous 
pathogen that has come to present staunch resilience against antibiotic treatments. One in three 
people in the world have tuberculosis (TB), and Mtb ranks as the second most deadly infectious 
agent in the world (in terms of deaths per year), falling behind only HIV/AIDS.30 It was long 
thought that treating Mtb with chemotherapy would not be possible, due to its lipid-rich cell wall.  
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Indeed, when penicillin and the sulfonamides were first developed, it was found that they 
had no action against Mtb. Eventually, however, drugs such as isoniazid were developed. In the 
early 1950s, isoniazid therapy was tested on a Navajo population that was heavily affected by 
TB. In those trials, the first ray of hope for an antibiotic treatment for TB emerged.31 Since those 
early days of treatment, Mtb has developed a multitude of resistances. The terms for 
classification of the various levels of resistance in Mtb allude to the severity of the problem at 
hand: multidrug-resistant (MDR), extensively drug-resistant (XDR), totally drug-resistant 
(TDR), and pan drug-resistant (PDR) tuberculosis.32  
The treatment course for TB now consists of 6 months of therapy during which patients 
take a combination of four drugs (isoniazid, rifampin, pyrazinamide, ethionaminde) for the first 
two months, and take just rifampin and isoniazid for the remaining four months.32 The 
particularly extended length of this therapy has led to issues stemming from patient non-
adherence, which has been shown by models to play a role in the evolution of drug resistance.33 
Those same models suggest that the rate at which the bacteria are killed is more important than 
the mutation rate, in terms of predicting the relative rates of development of resistant mutants.33 
Although we have not yet come to the absolute end of the era of antibiotics, it is certain 
that there is a race between the development of new drugs and pathogens’ capacity to become 
resistant to old drugs. Unfortunately, there has been a recent stagnation in the development of 
new antibiotics. In the four years between 1983 and 1987, the U.S. Food and Drug 
Administration (FDA) approved sixteen antibiotics for human use. In the four years between 
2008 and 2012, only two systemic drugs were approved.34 In the last 40 years, there have been 
zero new antibiotics for the treatment of Gram-negative bacilli.34 There are currently drugs in the 
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pipeline of clinical trials, but the development of new drugs alone is not a suitable solution for 
the problem of resistance. Slowing the rate at which resistant bacteria spread is critical to 
maintaining antibiotics’ medical efficacy. Another solution might involve the development of a 
method to suppress bacterial virulence without killing the organisms, thus avoiding artificial 
selection, but for now it seems that the use of effective antibiotics offers patients the greatest 
chance at achieving positive outcomes. 
Part of what hastens the development of antibiotic resistance is the fact that farmers often 
feed antibiotics to their livestock.35 In fact, the amount of antibiotics given to animals is about 
four times that given to humans each year; in 2009, animal use constituted 80% of all antibiotics 
consumed in the United States, and human use made up the other 20%.36 This is especially 
problematic if the same drugs that are used for human patients are regularly fed to animals – a 
common occurrence. About 61% of antibiotics sold for farm animals in 2009 were a type that is 
also medically important for humans.36  
Farmers have been giving antibiotics to animals since World War II, after they observed 
that their livestock were growing larger while under the effects of the drugs. Animals taking 
antibiotics provide more environments for the development of antibiotic resistant strains of 
bacteria, thus encouraging the rate at which resistant strains emerge. 
Antibiotic resistance has made its way to popular attention in recent years. With online 
article titles such as “Are you ready for a world without antibiotics?” and “7 scary facts about 
superbugs,” it seems as though the public is taking an interest in the issue.37, 38 A Google Trends 
insight suggests that the public’s interest in the topic is cyclical, with more search queries in the 
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winter months and fewer in the summer months.39 Although interest is seasonal, it appears that 
overall, interest in the issue is on the rise. 
The Centers for Disease Control's (CDC) announcement in the Summer of 2013 named 
antibiotic resistant Clostridium difficile, Carbapenem-resistant Enterobacteriaceae, and Neisseria 
gonorrhea as being “Threat level: Urgent.” There are strains of pathogens which are capable of 
overcoming every antibacterial agent that is currently in widespread use. Carbapenem-resistant 
Enterobacteriaceae (CRE) is resistant to carbapenem, which is often used as an antibacterial 
agent of last resort. There are about 9,300 CRE infections per year, with 600 resulting deaths.28 
Slightly less than one fifth of long-term stay hospitals in the United States had a patient with a 
severe CRE infection during the first half of 2012.40 Increasing trends of resistance, especially in 
the hospital setting, are alarming to researchers and medical professionals, and have implications 
reaching into the lives of the entire population. In 2005, methicillin resistant Staphylococcus 
aureus caused 94,000 infections and about 14,000 deaths in the United States alone.28, 40 
The economic burden caused by resistance to antibiotics has been estimated at $55 billion 
per year in the United States.41 Prospective estimates at the impact of complete antibiotic 
resistance reveal a frightening future. Currently, antibiotics are given prophylactically for 
patients undergoing hip replacement. The infection rate is about 0.5-2%, and most patients who 
do get infected can be properly treated. It has been estimated that in the absence of prophylactic 
antibiotics, infection rates would increase to roughly 40-50%, and that about 30% of those 
patients infected would die.42 Before antibiotic treatments were available, death rates from 
bacteremia caused by Staphylococcus aureus were around 80%.43 
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Indeed, the threat of infection would quickly present a terrifying deterrent to those 
considering spending time at a health care institution. This would lead to a decrease in treatments 
for non-life threatening disease states with high infection rates, which would increase the burden 
of various morbidities. 
The current use of prophylactic antibiotics for mothers undergoing cesarean section 
reduces the incidence of wound infection and serious complications by 60-70%.44 In a world 
without antibiotics, child birth would be considerably more dangerous. 
The question of how to reduce the negative impacts that resistant bacteria will have upon 
our medical system is simple. We can strive to increase the rate at which we produce novel 
antibiotics and we can strive to reduce the rate at which bacteria are developing antibiotic 
resistance. In order to reduce the rate at which bacteria are developing antibiotic resistance, it 
would be helpful to gain an understanding of why patients do not adhere to their antibiotic drug 
regimens. 
Patient behaviors and mentalities 
 A study conducted in an urban hospital environment suggested that patients often desire 
to be prescribed antibiotics, regardless of the cause of their illness. Patients seem to weigh their 
own potential benefit from antibiotic use more heavily than the possible negative side effects that 
may come about.45 
Moreover, when patients are prescribed antibiotics, they occasionally display patterns of 
non-adherence. This most often manifests in the form of patients forgetting to take their pills or 
intentionally stopping taking the antibiotics before they have completed their regimen. The most 
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common reasons for stopping their regimen are improved health state, forgetfulness, and 
negative side effects.46, 47 
A study investigating patients’ understanding of antibiotic resistance discovered a 
dominant theme of the thought that antibiotic resistance is a characteristic of a “resistant human 
body,” which is incorrect.48 The patients did not understand that it was the bacteria that were 
becoming resistant to the antibiotics. It has been suggested that this barrier in communication 
could be lessened by a label transformation away from “antibiotic resistance,” and toward a term 
that includes a direct reference to the bacteria themselves.49  
A prior study of factors that are associated with adherence to antiretroviral therapy found 
several lifestyle elements that are associated with proper adherence. These included having 
source of support from others (such as friends and family), having an intrinsic or extrinsic reason 
to adhere, and having a system for maintaining motivation.50 The belief that God was in control 
of the patient’s health status was found to be negatively associated with adherence.50 
 It could be beneficial to increase our understanding of patterns that are associated with 
non-adherence. Given sufficient insight into the underlying causes of non-adherence, physicians 
and clinical staff will be able to consult with their patients in a manner that will encourage 
optimal cooperation. 
 Patient adherence to other sorts of medical programs (such as endocrine therapy for 
breast cancer and lifestyle changes for cardiac patients) has been shown to be positively affected 
by an educational intervention providing enhanced information to patients.51, 52 It would seem as 
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though enhanced education on the topic of antibiotic resistance could also lead to increased 
patient adherence to drug regimens. 
 This study seeks to identify patterns that are associated with non-adherent subjects. 
Importantly, we will explore knowledge of basic biology related to antibiotic resistance as a 
potential distinguishing feature between the profiles of non-adherent and adherent patients. 
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CHAPTER 2: METHODS 
 A survey containing three sets of questions was used to gather the responses for this 
study. Participants were students at the University of Central Florida from a variety of academic 
majors. Respondents were recruited via UCF’s SONA Research Participation System. All 
participation was carried out online. The three sections of the survey were i) adherence 
questions, ii) science questions, and iii) demographic and miscellaneous questions. 
 The combination of a previously developed53 adherence questionnaire, original science 
questions, and demographic information obtained was utilized to find associations with predicted 
non-adherence. 
 The exclusion criteria were: (1) Being under the age of 18; (2) Choosing “I want to 
withdraw from this study” as a response at any point in the survey; (3) Failing at least one of the 
two questions designed to identify those who were not reading the questions; (4) Submitting an 
incomplete set of responses; (5) Repeated submissions from the same subject (Spam). 
 This study was approved by the University of Central Florida’s Institutional Review 
Board (IRB) as human participant research that is exempt from regulation (IRB Number: SBE-
14-10481). 
Survey Section 1: Adherence questions 
 There were four adherence questions given in the first section of the survey. These four 
questions were developed as a means of predicting whether patients would properly adhere to 
their antibiotic regimens. The questions are rooted in the World Health Organization’s (WHO) 5 
dimension adherence model.54 
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 For each question, there was only one answer option that was considered to be the 
“adherent” response. In this study, the total number of the subjects’ “adherent” responses were 
considered to be their “adherent scores.” The minimum possible adherence score was zero, and 
the maximum was four. 
 A previous study determined that subjects who “adherently” answered only 0, 1, or 2 of 
these four adherence questions were more likely to be non-adherent with respect to their 
antibiotic regimens.53 Subjects who chose the “adherent” response in 3 or 4 of the adherence 
questions were more likely to be adherent. This system provided good sensitivity, specificity, 
and total predictive value (80%, 82%, and 81%, respectively) in their sample.53 
   
Adherence Question 1: Convenience 
“Is taking medicine more than once a day inconvenient?”  
(Yes, No) 
 The “adherent” answer for this question was “No.” Patients who do not view taking 
medicine more than once a day as being inconvenient are considered to be more likely to be 
adherent. 
Adherence Question 2: Uncertainties 
“Whom do you consult first if you have any uncertainties about medicine use?” 
(Physician/Pharmacist, Not Physician/Pharmacist) 
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 The “adherent” answer for this question was “Physician/Pharmacist.” Patients who are 
likely to consult trained healthcare providers are more likely to be adherent. 
Adherence Question 3: Forgetfulness 
“Do you ever forget to take medicine if it has been prescribed to you?” 
(Yes, No) 
 The “adherent” answer for this question was “No.” Patients who do not forget to take 
their medicine are less likely to accidentally become non-adherent to an antibiotic regimen. 
Adherence Question 4: Health state 
“How will you behave if your health state improves after a few days of taking an antibiotic?” 
(Continue taking the antibiotic as prescribed, Continue to take the antibiotic at a reduced dosage, 
Discontinue taking the antibiotic) 
 The “adherent” answer for this question was “Continue taking the antibiotic as 
prescribed.” Discontinuing taking the antibiotic and taking the antibiotic at a lower dose would 
increase the chance for a resilient type of bacteria to survive and replicate in the host. 
 Survey Section 2: Basic biological questions addressed in this study 
 There were ten science questions given in the second section of the study. Each addressed 
a topic is related to the topic of bacteria, disease, or antibiotic resistance. The subjects’ scores out 
of ten were considered to be their “science scores.” 
18 
 
 Some of the questions were framed in relatively colloquial terms in order to avoid 
alienating non-expert respondents. All questions were in True/False format. A third option, “I do 
not know,” was available for each question, and was considered to be an incorrect response. 
Science Question 1: Power of drugs 
“Standard doses of penicillin (a type of antibiotic) can kill any bacteria that might be infecting 
your body.” 
(True, False) 
 The correct answer for this question was “False.” An analysis of clinical isolates in the 
United States in 1999-2000 discovered roughly 34% of S. pneumoniae isolated from patients to 
be “penicillin nonsusceptible.”25 Penicillin resistance was observed as early as 1942.23  
Science Question 2: Antibiotics and viruses 
“If you have a virus, taking antibiotics will kill the virus more quickly than your body can on its 
own” 
(True, False) 
 The correct answer for this question was “False.” Antibiotics are uniquely targeted to 
affect bacteria, which are distinct from viruses. Antibiotics have no effect on viruses.9 
 
 
 
19 
 
Science Question 3: Bacterial DNA 
“All bacteria have DNA.” 
(True, False) 
 The correct answer for this question was “True.” If bacteria did not have DNA, they 
would not successfully reproduce and would have no mechanism for encoding the proteins and 
ribonucleic acid that give rise to their physical form.55-57 
Science Question 4: Commensal flora 
“It is normal and healthy to have lots of bacteria on your skin and in your body.” 
(True, False) 
 The correct answer for this question was “True.” Humans live with roughly 1013 bacteria 
in and on them at all times. This is ten times more than the average number of human cells each 
person has (1012). The microbiome of the gut plays important roles in host digestion and immune 
function.58 One square centimeter of human skin can contain roughly 109 bacteria.59 These 
commensal bacteria play important roles in outcompeting potentially harmful pathogens.59 
Science Question 5: The gut 
“If you were found to have bacteria inside of your intestines, you should probably take 
antibiotics as soon as possible.” 
(True, False) 
 The correct answer for this question was “False.” Bacteria inside the intestines are 
responsible for the production of vitamin K, which is essential for forming blood clots.18, 19 The 
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intestinal flora are also helpful to their human hosts, as they take up environmental niches that 
deleterious pathogens might otherwise be able to occupy. Clostridium difficile, one of the 
pathogens detailed in the 2013 Centers for Disease Control report on antibiotic resistance,28 often 
establishes an infection after a patient has been on an antibiotic regimen that killed a portion of 
their normal resident bacterial community in the gut. This can lead to a severe disease state, and 
is a functional example of why intestinal bacteria shouldn’t collectively be thought of as a 
problem.28 
Science Question 6: Evolution of resistance 
“Evolution of bacteria has never been directly observed, and is only a theory.” 
(True, False) 
 The correct answer for this question was “False.” Examples of the genetic effects of 
selective pressures placed upon bacteria are well represented in the literature.11, 21, 32, 33 There is 
some merit to the claim that genetic changes that have resulted from the intelligent intervention 
of humans are not true examples of evolution, but are instead artificial selection.  
 Humans, however, are not the only users of antibiotics. In fact, many of the antibiotic 
compounds that we now employ have been in use by other organisms (such as the Penicillium 
molds) for tens of thousands of years; 30,000 year old Beringian permafrost was discovered to 
contain bacterial genes encoding resistance to β-lactam, tetracycline, and glycopeptide 
antibiotics.22 
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Science Question 7: Bacterial resilience 
“Bacteria are capable of becoming immune to our most powerful antibiotics.” 
(True, False) 
 The correct answer for this question was “True.” Bacteria that are resistant to every 
known antibiotic compound pose a frightening threat. Extensively drug-resistant tuberculosis, for 
example, has been observed to become resistant even to the most effective second-line 
antibiotics.1 
Science Question 8: Bacteria vs. viruses 
“’Bacteria’ and ‘Virus’ are two words that mean the same thing.” 
(True, False) 
 The correct answer for this question was “False.” Bacteria are single celled, living 
organisms that contain organelles such as mitochondria and ribosomes that are used in 
maintaining cellular processes.60 Viruses are comprised of genetic material encased in a capsid, 
and are only capable of replicating after taking control of a host cell’s internal machinery.60 
Science Question 9: Do professionals agree 
“There is a consensus among scientists and doctors that antibiotic-resistant bacteria are becoming 
a problem” 
(True, False) 
 The correct answer for this question was “True.” It has been thoroughly established that 
bacteria i) have already developed resistances to some drugs, ii) have the potential to become 
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resistant to an even wider variety of compounds, and iii) will lead to significantly more negative 
clinical outcomes if they are not able to be successfully treated.6, 21, 25, 27, 28, 30, 40, 61, 62 
Science Question 10: Are antibiotics more effective than placebos 
“Pharmaceutical companies suggest the use of antibiotics because they profit off of them. In 
reality, antibiotics are not statistically more effective than taking a sugar pill, or another type of 
placebo.” 
(True, False) 
 The correct answer for this question was “False.” Although pharmaceutical companies 
may promote antibiotics because they have a vested interest in their sales, it has been objectively 
established that antibiotics are more effective than placebos when used for their intended 
purpose.7, 8, 15, 63, 64 
Survey Section 3: Demographic and miscellaneous questions 
 The information gathered from this group of questions was not accumulated to make up a 
certain score, but was used to evaluate patterns among various groups of subjects. Several of the 
questions in this category were also intended to identify respondents who were randomly filling 
in answers to the survey and not reading the questions. 
Demographic & Misc. Question 1: Age 
“What is your age?” 
 Subjects were grouped into several age divisions: 18, 19, 20, 21, 22, 23-30, 31-40, 41-50, 
51-60, 61-70, 70+. 
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Demographic & Misc. Question 2: Sex 
“What is your sex?” 
(Male, Female, Other) 
Demographic & Misc. Question 3: Major 
“Is your major related to Biology?” 
(I am majoring in Biology, Biomedical Science, Biotechnology, or a related track; I am majoring 
in another STEM [Science, Technology, Engineering, and Math] track that is not similar to 
Biology; I am not majoring in STEM or Biology) 
 This grouped respondents into the categories of (i) biology-related majors; (ii) STEM 
majors (other than biology-related); (iii) not related to STEM or biology 
Demographic & Misc. Question 4: Antibiotic history 
“Have you ever been prescribed antibiotics?” 
(Yes, No, I am not sure) 
Demographic & Misc. Question 5: Opposition to antibiotics 
“Are you generally opposed to the use of antibiotics?” 
(Yes, No) 
Demographic & Misc. Question 6: Awareness of issue 
“Have you heard of the problem of antibiotic resistance?” 
(Yes, No) 
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Demographic & Misc. Question 7: Self-rated understanding 
“How would you rate your understanding of the topic of antibiotic resistance?” 
(Very Poor, Poor, Fair, Good, Excellent) 
 These responses were translated into scores ranging from 1-5, respectively. In this way, 
they were able to be considered quantitatively. 
Demographic & Misc. Question 8: Remembering to take doses 
“If you were to be prescribed antibiotics, would you be responsible for remembering to take your 
doses?” 
(Yes, No) 
 The two resulting groups determined by this question (autonomous and non-autonomous) 
were compared by mean adherence scores to determine if there was significant difference.  
Demographic & Misc. Questions 9 and 10: Eliminating confounding respondents 
Agreement to not guess 
“If you are not sure about an answer, please do not guess. Guessing has the potential to throw off 
the data of the study. If you don’t know an answer, just select the ‘I do not know option.’ 
Thanks!” 
(I will select “I do not know” if I don’t know the answer, I will guess when I do not know the 
answer) 
 This question was asked before the subjects were presented with the science questions. 
The correct answer for this question was “I will select ‘I do not know’ if I don’t know the 
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answer.” Since all of the science questions were presented as True/False, there is a potentially 
misleading effect that would result from respondents guessing on questions they don’t know.  
With the addition of an “I do not know” answer option to each science question, the 
survey results allow insight into how many answer the respondents actually knew the material, 
rather than how many knew the material plus how many managed to correctly guess. 
Respondents who selected the incorrect option for this query were eliminated from the study. 
Ensuring attentive responses 
“This question isn’t really a part of the quiz. Please select “False” as your answer to this 
question.” 
(True, False, I do not know) 
 This question was placed between the 7th and 8th science questions in the survey. 
Respondents who chose “True” or “I don’t know” were eliminated from the study, with the 
understanding that they were most likely selecting random answers (or entirely “I do not know”) 
through the science section. 
Statistical Analysis 
 The analysis of the various components of subject responses was conducted using MS 
Excel. For the nominal variables, absolute numbers and frequencies were used for comparison. 
For quantitative variables (such as science score), means (M) and standard deviations (SD) were 
calculated. The relationships between elements of the study were analyzed using: (1) Student’s 
two-tailed unpaired t-test for comparison of mean measurement variables between groups; (2) 
one-way ANOVA to determine if the means of the measurement variable were the same between 
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multiple groups; (3) Fisher’s exact test of independence to determine if differences in one 
nominal variable vary significantly with the value of another nominal variable. All Fisher’s 
calculations were done two-tailed, using the method of summing small P values. Normalcy was 
visualized using a Quantile-Quantile (QQ) plot. 
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CHAPTER 3: RESULTS 
A total of 961 responses were evaluated. Out of these, 117 responses were removed from 
the study after having met at least one of the exclusion criteria, leaving 844 responses to be 
considered. Error bars on figures displaying averages represent standard error of the mean. Error 
bars on figures displaying proportions represent the 95% confidence interval (α=0.05). 
Distribution of responses 
Adherence scores 
 
Figure 1: Distribution of adherence responses 
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Figure 2: Distribution of adherence responses 
 
 
Figure 3: QQ plot of adherence scores 
For this QQ plot, Data values (adherence scores) are represented by the Y axis, and the 
theoretical quantiles are shown by the X axis. QQ plots are used to visualize how the data 
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collected compare to a theoretically perfectly normally distributed data set. If the actual data 
collected are completely normal, the plot gives a straight diagonal line. In this case, a slight 
curve under the diagonal on the right hand side suggests a somewhat heavy right tail. This 
indicates that the normal distribution of responses is translated slightly to the right, spilling off 
the bounds of the 0-4 scale used for measurement. If a fifth adherence question had been added, 
it is likely that the right tail would have lightened. 
Science scores 
 
Figure 4: Distribution of science scores 
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Figure 5: QQ plot of science scores 
Data values (science scores) are represented by the Y axis and the corresponding 
theoretical quantiles are shown by the X axis. There is no systematic deviance from the QQ plot. 
Slight S shape indicates light tails in both directions, with no apparent outliers. 
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Significant difference in science scores between adherent and non-adherent groups 
 
Figure 6: Science scores of adherent and non-adherent subjects 
An independent samples t-test was conducted in order to compare scores (out of 10) on 
the science section in non-adherent and adherent respondents. Error bars represent standard error 
of the mean. There was a significant difference in the science scores for non-adherent (M=4.99, 
SD=2.46), and adherent (M=5.46, SD = 2.52) subjects; t(842)= -2.73, p = 0.0064. This suggests 
that there is a meaningful difference in the science knowledge between patients who are likely to 
be non-adherent/adherent. 
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Differences by age 
Adherence scores 
A one-way ANOVA was conducted to compare the effect of age on adherence responses. 
There was not a significant effect of age on average adherence score [F(9,827) = 0.954, p = 
0.48]. Seven respondents did not wish to report their age.  
 
Figure 7: Age vs. average adherence 
Science scores 
 Another one-way ANOVA was conducted in order to compare the effect of age on 
science score. There was not a significant effect of age on sciences scores [F(9,827) = 1.86, p = 
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0.055]. This p value is significantly closer to the statistical cutoff of 0.05 than it was in the 
adherence ANOVA (p=0.48), suggesting that age is closer to being associated with scores on the 
science section than it is with scores on the adherence section. 
 
Figure 8: Age vs. mean science score 
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No difference in adherence scores in autonomous and non-autonomous Subjects 
An independent samples t-test was conducted in order to compare mean adherence scores 
(out of 4) autonomous and non-autonomous subjects. Subjects were grouped into the 
autonomous category if they said that they were responsible for remembering to take their doses. 
Subjects were grouped into the non-autonomous category if they indicated that someone else 
helped them remember to take their doses. There was no significant difference found in the 
adherence scores for autonomous (M=2.38, SD=0.98, n=37), and non-autonomous (M=2.54, SD 
= 1.04, n=807) subjects; t(842)= 0.98, p = 0.33. 
No difference in adherence scores in those who had and had not heard of antibiotic 
resistance 
To investigate whether there was a meaningful relationship between having heard of 
antibiotic resistance and adherence scores, an unpaired t-test was conducted. Of the 844 subjects, 
626 (74%) had heard of the problem of antibiotic resistance. There was no significant difference 
found in the adherence scores for those who had heard of antibiotic resistance (M=2.40, 
SD=0.99, n=626), and those who had not heard of antibiotic resistance (M=2.35, SD = 0.98, 
n=218) subjects; t(842)= -0.64, p = 0.52. 
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Strong relationship between knowledge that bacteria and viruses are different and that 
antibiotics do not kill viruses 
 
Incorrect (Bacteria 
and viruses are the 
same) 
Correct (Bacteria 
and viruses are 
different) 
Total 
Incorrect (Antibiotics kill 
viruses / don’t know) 
106 444 549 
Correct (Antibiotics don’t 
kill viruses) 
10 284 295 
Total 116 728 844 
Figure 9: bacteria vs. viruses and antibiotics on viruses 
Out of the 844 respondents, 116 did not know that bacteria and viruses are not two words 
for the same thing. A total of 549 subjects did not know that antibiotics have no effect on viruses. 
A 2x2 Applying Fisher’s test of independence, the proportion of knowing that antibiotics do not 
kill viruses was found to be significantly higher (p < 0.0001 ) in those subjects who did know 
that bacteria and viruses are different. 
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Test for relatedness between knowledge that bacteria and viruses are different and that 
antibiotics are more effective than placebos 
 
Incorrect (Bacteria 
and viruses are the 
same) 
Correct (Bacteria 
and viruses are 
different) 
Total 
Incorrect (Antibiotics are 
placebos / I don’t know) 
81 329 410 
Correct (Antibiotics work 
better than placebos) 
35 399 434 
Total 116 728 844 
Figure 10: bacteria vs. viruses and placebo comparison 
A total of 410 subjects did not know that antibiotics are more effective than placebos. 
Applying a 2x2 Fisher’s exact test of independence, the proportion of respondents who knew that 
antibiotics are more effective than placebos was found to be significantly higher (p < 0.0001) in 
those subjects who did know that bacteria and viruses are different. 
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Does opposition to the use of antibiotics affect adherence proportion 
  Non-Adherent Adherent Total 
Opposed to the use of 
antibiotics 
77 50 127 
Not opposed to the use of 
antibiotics 
375 330 705 
Total 452 380 832 
Figure 11: Opposition and adherence 
Of the 844 respondents, 12 did not wish to respond to the demographic question 
regarding whether they were opposed to the use of antibiotics in general. Of the 832 who did 
respond, 127 were opposed to the use of antibiotics, and 705 were not. Applying a 2x2 Fisher’s 
exact test of independence suggests that there is not a significant relationship (p = 0.15) among 
the proportions of adherent and non-adherent subjects, depending on whether they were opposed 
to the use of antibiotics. 
Does major affect adherence proportion 
 Of the 844 Respondents, 799 were willing to report their major. Multiple Fisher’s exact 
tests of independence were run to test whether major was predictive of adherence. Subjects were 
grouped into three categories of major: (1) Biology-related; (2) STEM, but unrelated to biology; 
(3) Not related to biology or STEM. 
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Biology-related majors 
  Non-Adherent Adherent Total 
Not Biology-Related 324 279 603 
Biology-Related 109 87 196 
Total 433 366 799 
Figure 12: Biology majors and adherence 
Applying a 2x2 Fisher’s exact test of independence suggests that there is not a significant 
relationship (p = 0.68) among the proportions of adherent and non-adherent subjects, depending 
on whether they had a biology-related major. 
Not biology or STEM 
  Non-Adherent Adherent Total 
Not Biology or STEM 277 219 496 
Biology or STEM 156 147 303 
Total 433 366 799 
Figure 13: Non biology or STEM majors and adherence 
Applying a 2x2 Fisher’s exact test of independence suggests that there is not a significant 
relationship (p = 0.24) among the proportions of adherent and non-adherent subjects, depending 
on whether they had a major unrelated to biology or STEM. 
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STEM (not including biology-related majors) 
 
Figure 14: Proportion of adherence, STEM majors vs. others 
  Non-Adherent Adherent Total 
Biology or not STEM 386 306 692 
STEM 47 60 107 
Total 433 366 799 
Figure 15: STEM majors and adherence 
Applying a 2x2 Fisher’s exact test of independence suggests that there is a significant 
relationship (p = 0.028) among the proportions of adherent and non-adherent subjects, depending 
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on whether they had a major related to STEM (but not biology). This indicates that STEM 
majors (not including biology) were more likely to be adherent when compared to other majors. 
Accuracy in self-assessment of science knowledge 
 
 
Figure 16: Self-rated score distribution 
The above chart (Figure 16) is a representation of the distribution of self-assessed 
understanding of the topic of antibiotic resistance. 
The accuracy with which subjects rated their own knowledge of antibiotic resistance was 
calculated by comparing their self-rated score (0-4) with their science score (0-10). To obtain a 
“self-rated accuracy score,” the subjects’ self-rated number was multiplied by 2.5. Their science 
score was then subtracted from that number: 
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2.5(self-rated score) – (science score) = (accuracy score) 
 Using this definition, overestimates of knowledge would lead to a positive accuracy 
score, and underestimates would lead to a negative accuracy score. An example calculation 
would be as follows: 
 If one particular subject scored a 6 out of 10 on the science section and they self-rated 
their understanding of antibiotic resistance as being 3 out of 4 their accuracy score would be: 
2.5*(3) – 6 = 1.5 
 This particular subject would be said to have overestimated their knowledge of biological 
topics related to antibiotic resistance. 
 Data from the accuracy scores of the entire sample (n = 844) showed a mean of -0.36 and 
a standard deviation of 2.43, suggesting a slight underestimation of knowledge, on average. 
No difference in adherent and non-adherent subjects’ accuracies in self-assessment of 
science knowledge 
A two-tailed independent samples t-test was conducted in order to compare mean 
accuracy scores of adherent and non-adherent subjects. There was no significant difference 
found in the self-rated accuracy scores for non-adherent (M= -0.40, SD=2.43, n=460), and 
adherent (M= -0.32, SD = 2.44, n=384) subjects; t(842) = 0.186, p = 0.85. 
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No significant difference in self-rated knowledge scores between those who had and had not 
heard of antibiotic resistance 
A two-tailed t-test revealed no significant difference in the self-reported “understanding 
of the topic of antibiotic resistance” scores between those who had heard of the topic of 
antibiotic resistance (M=1.91, SD = 0.95, n=626) and those who had not (M=2.02, SD = 0.91, 
n=218) subjects; t(842)= 1.49, p = 0.14. 
Does sex matter 
Significant relationship between sex and science score 
 
Figure 17: Sex vs. science score 
A two-tailed independent samples t-test was conducted in order to compare mean science 
scores of male and female respondents. There was a significant difference found in the science 
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scores of males (M=5.50, SD=2.44, n=311) and females (M=5.02, SD=2.44, n=524); t(833) = 
2.70, p = .007. 
Significant relationship between sex and adherence 
 
Figure 18: Sex and adherence 
Of the 311 males who responded, 161 of them were determined to be adherent (52%). Of 
the 524 females who responded, 218 were determined to be adherent (42%). Applying a 2x2 
Fisher’s exact test of independence yields p = 0.005; there is a significant difference in the 
adherent/non-adherent ratio between males and females. 
Adherent and non-adherent subjects took the same amount of time 
A two-tailed independent samples t-test was conducted in order to compare mean times 
spent taking the questionnaire. 
There was no significant difference found in the times to completion of non-adherent 
(M=5.94 minutes, SD=6.32 minutes, n=460), and adherent (M=5.47 minutes, SD = 5.20 minutes, 
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n=383) subjects; t(841) = 1.16, p = 0.25. Adherent and non-adherent respondents took the same 
amount of time to complete the questionnaire. 
A look at the respondents 
How many subjects had ever previously been prescribed antibiotics? 
  
Figure 19: Have you ever been prescribed antibiotics 
 It was determined that 770 (91%) of the 844 respondents said that they had previously 
been prescribed antibiotics. 
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How many subjects said they were “generally opposed” to the use of antibiotics? 
 
 
Figure 20: Are you generally opposed to the use of antibiotics 
 Most respondents (85%; n=706) were not generally opposed to the use of antibiotics. 
How many subjects had heard of the problem of antibiotic resistance? 
 
Figure 21: Have you heard of the problem of antibiotic resistance 
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Are you generally opposed to the use of 
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46 
 
 The majority of respondents (74%; n=626) reported having heard of the problem of 
antibiotic resistance, but 26% (n=218) said that they were not familiar with the issue. 
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CHAPTER 4: DISCUSSION 
 Contributions to our understanding of the differences between adherent and non-adherent 
patients will allow physicians and health care staff to tailor drug regimen guidelines and 
explanations to individual patients. This is important because patient adherence is directly linked 
to discouraging the development of antibiotic resistant strains of bacteria. This study sought to 
examine the response profiles of adherent and non-adherent patients, with the translational goal 
of building upon our understanding of what features might distinguish those two groups. 
The distribution of subjects’ responses to several components of the questionnaire 
suggests relatively normal proportions. Responses to the four adherence questions were used to 
classify each respondent as being non-adherent (less than 3 adherence questions correct) or 
adherent (3 or 4 adherence questions correct). The distribution of adherence scores had a slightly 
heavy right tail, indicative of a potential translation to the right that was cut off by the upper 
score boundary set at 4. The direct regression between adherence scores and science scores was 
not relevant because adherence scores were being used to group respondents. The distribution of 
science scores had somewhat light tails on either side, suggesting that science knowledge among 
the respondents carried tendencies toward the center. 
 The relationship between adherence and science was determined to be statistically 
significant. The null hypothesis that adherent and non-adherent subjects would have equal means 
was rejected with a p value of 0.0064. This showed that adherent subjects demonstrated a higher 
level of education on the science topics presented, relative to their non-adherent counterparts. 
This result alludes to the findings of previous studies on the impacts of patient education on 
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adherence to various other types of regimens, including endocrine therapies for cancer patients 
and lifestyle changes for cardiac patients.51, 52 
 This finding opens the door to potential avenues by which the issue of patient non-
adherence may be addressed. Increasing efforts at patient education could lead to a decreased 
rate of patient non-adherence. In turn, a reduction in patient non-adherence will lead to less 
opportunities for bacteria to become resistant to antibiotics. Although this will reduce the rate at 
which antibiotic resistant bacteria will develop, it is by no means a mechanism by which to 
completely halt the evolution of resistant mechanisms. Improving adherence is suggested only as 
a method to slow down the development of that resistance. 
There are many possible avenues by which increased patient education can be obtained. 
The source of information could begin in the entertainment sector. News outlets could present 
the topic of antibiotic resistance from an educational standpoint, rather than speaking about the 
frightening possibility of superbugs. Patient education could continue in the doctor’s office, 
where educational handouts could be distributed with each prescription for antibiotics. 
Pharmacies who fill orders for antibiotics could then reinforce the previous messages by 
including reminder messages to complete the entire drug regimen, even if the patients start 
feeling better. 
Organizations such as the Centers for Disease Control already create and publish 
informational pamphlets on the topic of antibiotic resistance.65 Although these pamphlets are in 
production, it seems that they are not fully addressing the needs of the population assessed in this 
study. This could be due to a lack of availability; it is possible that many of the subjects in this 
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study have not previously visited the CDC website or come across a printed version of those 
materials. In this social-media dominated age of information, efforts at public awareness could 
be made through a variety of channels.  
 It was determined that the only group of students that was significantly more likely to be 
adherent was STEM majors (not including majors related to biology). The null hypothesis that 
subjects with majors related to biology would be equally likely to be adherent (when compared 
with non-biology-related majors) was not able to be rejected; subjects with majors related to 
biology were not shown to be more adherent than subjects whose majors were not related to 
biology. Similarly, subjects whose majors were related to neither biology nor STEM were not 
shown to be more adherent than biology and STEM majors. 
 Men were shown to be significantly more likely to be adherent and also more 
knowledgeable in the biological competencies assessed in this study. This is a logical grouping 
of correlations, given the association found between knowledge and adherence (Figure 6). 
Adherent and non-adherent respondents took the same amount of time to complete the 
questionnaire. It was estimated that subjects would take less than 15 minutes to complete the 
survey. This ended up being true for 96% (n=814) of the respondents. 
 Overall, respondents seemed to be fairly good at estimating their knowledge on the 
subject of antibiotic resistance. Subjects displayed an average accuracy score of roughly -0.36. 
This means that subjects slightly underestimated their knowledge, on average. 
 Future studies could examine the impact of educational interventions on the adherence 
rate of patients. Such studies would benefit from using a clinical model of adherence, rather than 
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relying upon a survey, as did this study. Counting pills and interacting with actual patients would 
provide a more reliable grouping of adherent and non-adherent subjects than this study was able 
to achieve.  
The results in Figure 19 demonstrate that 91% of subjects included in this study have 
been prescribed antibiotics in the past (i.e. they have real world experience with antibiotics). The 
remaining 9% included those who were not sure if they had been prescribed antibiotics in the 
past (3%), so the real number of subjects with past experience with antibiotics is likely to be 
higher than 91%. 
 Several unexpected results were observed over the course of data analysis. About 65% of 
subjects were not aware that antibiotics are ineffective against viruses. Furthermore, it was 
discovered that 13.7% of respondents did not know that viruses and bacteria are different. 
 This finding brings to light the potential source of a fundamental disconnect between 
physicians, researchers, and patients. Public service announcements that spread information on 
the fact that antibiotics are only effective against bacteria do not seem to have been effective for 
most of the subjects in this study. Importantly, such announcements will be of little use to 
patients who do not recognize that there is a difference between bacteria and viruses. 
 It was found that 48.6% of respondents did not know that antibiotics are more effective 
than placebos. If patients believe that the medication that they have been prescribed is not truly 
effective, they have less reason to continue taking their doses as prescribed. To individual 
patients, the negative consequences that might result from stopping a regimen partway through 
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are not nearly as recognizable as the potential positive consequences (such as an immediate 
tangible reduction in unpleasant side effects).48 
 Doctors and nurses who are made aware of the types of misunderstanding that could be 
taking place during their exchanges with patients will have the opportunity to allocate more 
attention to ensuring that the patient is up to speed with the basic biological principles underlying 
their disease. This assumes that doctors and nurses themselves have a good understanding of the 
topic at hand. While this intuitively seems like it would be the case, past research has indicated 
that up to 43.5% of pediatricians overestimate the risks of not prescribing antibiotics in 
conditions such as ear infections and tonsillitis.66  
 From a systemic approach, increased education on basic biological facts related to the 
development of antibiotic resistance could help to lessen the gap between patients and health 
care professionals, bringing their understandings closer together before patients even step foot in 
the examination room. Physicians could be made more aware of the realities of antibiotic 
outcomes, and patients could be made more aware of the potential consequences of their decision 
to be non-adherent.  
The results visualized in Figure 21 show that about 24% of respondents had not heard of 
the problem of antibiotic resistance. The most basic step in increasing the level of education of 
the public will be ensuring that everyone is at least aware that antibiotic resistant bacteria are a 
problem. Another step will be ensuring that doctors are aware of actual trends in the 
development of resistance. The White House’s 2016 budget allocations for combatting antibiotic 
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resistant bacteria will arm doctors with a variety of tools, such as the ability to monitor resistance 
geographically in real time, which should help refine prescription tendencies.67 
 The development of antibiotic resistant strains of bacteria is a threat that must be tamed 
from a variety of angles. Even as drug discovery teams race to develop new classes of drugs and 
farmers are pressured to use less medically important antibiotics in their livestock, clinicians and 
patients must each do their part to increase their understanding of the issues at hand and seek to 
maximize positive outcomes brought about by proper adherence to antibiotic regimens. 
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